Find a TenderAwardedContract details notice
Published 3 Sept 2025, 15:37 BST

Official UK procurement notice

NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin

Official notice

Authority: NHS England (Central government)

Framework agreementGoodsOpen procedureAbove thresholdSME suitable
Framework ceiling (notional)£37,954,000framework ceiling, not attributable revenue · 1 value update
Submissions closed 31 Oct 2025awarded 25 Nov 2025
Award (standstill) to ACCORD-UK LTD +7 more
Framework period 1 yr 8 moends 30 Sept 2027 · up to 30 Sept 2029 with extensions · starts 1 Feb 2026

What is being bought

Published requirement description

Project title: NHS National Framework for Transition Products (Apremilast, Pazopanib and Dapagliflozin) commencing 1st February 2026

Offer reference number: CM/TNS/25/5735

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.

Potential periods of call-offs under the framework agreement:

CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin

Lot 1 DLN/DNW: 01/02/2026 to 31/01/2027 (12 months)

Lot 2 DLS/DNE: 01/02/2026 to 31/01/2027 (12 months)

Lot 3 DCE/DSW: 01/02/2026 to 30/09/2027 (20 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

CPV: Pharmaceutical products

How this framework works

From the published notice
Type
Closed framework
Call-offs
every call-off is a further competition among the appointed suppliers
Bids received
8 bids received · 9 suppliers appointed
Framework period
1 yr 8 mo · up to 3 yrs 8 mo from 1 Feb 2026
Who may buy through it

Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points

Published description of the framework

Please refer to the ITO Documents for the Operation Description

The lotProcurement structure

single lot · value published
Lot #1AwardedRenewal 1 yr 8 moSMEPublished value£37,954,000
Contract period: 1 Feb 2026 – 30 Sept 2027 (1 yr 8 mo) · up to 30 Sept 2029 with extensionsValue: £37,954,000 exc. VAT · £45,544,800 inc. VAT
Extensions: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored
Price: 100%
Published sub-criteria (1)
  • Price is not the only award criterion: 100%
Published award criteria (1)
  • Price is not the only award criterion
What this means for your bid
  • Price carries 100 of 100 points: a 10% discount moves about 10 points. This one is won on the number: sharpen the price before polishing the prose.
  • “NHS National Transition Framework for Apremilast, Pazopanib and…” is a framework: the contest is a place on its panel, not a single contract: each call-off is a further competition, so the pricing contest starts after appointment.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record
Procedure method
Open procedure
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Procurement category
Goods
Notice status
Awarded
Procurement threshold
Above threshold (FTS publication)
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Please refer to Document No. 09 in the ITO Documents for the list of Purchasing Points
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
Unspecified in notice
First published
3 Sept 2025, 15:37 BST
Last source update
30 Jan 2026, 09:48 GMT
Award evaluation window
Submission end – 27 Nov 2025
Authority reference
C386886
FTS notice number
2025/S 000-061712
Latest notice
Contract details notice (UK7)
Classification (CPV)
Pharmaceutical products
Delivery area
North East (UKC)North West (UKD)East Midlands (UKF)West Midlands (UKG)East of England (UKH)South East (UKJ)South West (UKK)
Official registry OCID
ocds-h6vhtk-05936a Find a Tender

How it was run

Official notice
Run through: Atamis legacy domain (health-family.force.com) · Who buys & how to bid on Atamis
Supplier login requiredElectronic submission allowedLanguage: EN
Access & registration note: Legacy Salesforce domain still used in notices — use the current Atamis portal · this portal address is a legacy domain; the operator has migrated
Appointment period ends
31 Oct 2025, 13:00 GMT
Clarification deadline
24 Oct 2025, 13:00 BST
Submission channel
Official e-sourcing portal
Electronic submission
Allowed
Accepted languages
en
Detailed submission instructions & authority contactsFrom official release

The procurement documents are available for unrestricted and full direct access, free of charge at health-family.force.com/s/Welcome ↗

Additional info obtained from the abovementioned address

Tenders must be submitted to the abovementioned address

Timeline

3 Sept 2025 → 1 Feb 2026 · 11 dates
  1. Planning notice published
    3 Sept 2025, 15:37 BST
  2. Market engagement398 days ago
    18 Sept 2025, 23:59 BST

    NHS England is seeking to engage with suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting.

    The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's.

    Please contact [email protected] or [email protected] to register your interest in tendering for this framework.

    Please indicate which products your company is planning to bring to market in your response.

  3. Tender notice published385 days ago
    2 Oct 2025, 13:32 BST
  4. Next notice expected384 days ago
    2 Oct 2025, 23:59 BST
  5. Clarification questions by363 days ago
    24 Oct 2025, 13:00 BST
  6. Admission / appointment period ends356 days ago · period end, not a bid countdown
    31 Oct 2025, 13:00 GMT
  7. Assessment summaries sent330 days ago
    26 Nov 2025
  8. Award decision expected by328 days ago
    27 Nov 2025, 23:59 GMT
  9. Standstill ends317 days ago
    8 Dec 2025, 23:59 GMT
  10. Latest notice published265 days ago
    30 Jan 2026, 09:48 GMT
  11. Contract starts263 days ago
    1 Feb 2026

Notice history

10 events · 4 releases on Find a Tender · since 3 Sept 2025
  1. Preliminary market engagement notice published
    3 Sept 2025, 15:37 BST
    UK2
  2. Tender notice published
    2 Oct 2025, 13:32 BST
    UK4
  3. Published value updated to £37,954,000
    2 Oct 2025, 13:32 BST
    was £35,500,000
  4. Status changed to active
    2 Oct 2025, 13:32 BST
  5. Procurement method changed
    2 Oct 2025, 13:32 BST
  6. Deadline published: 31 Oct 2025, 13:00 GMT
    2 Oct 2025, 13:32 BST
  7. Contract award notice published
    26 Nov 2025, 15:36 GMT
    UK6
  8. Status changed to complete
    26 Nov 2025, 15:36 GMT
  9. Contract signature expected
    19 Dec 2025, 23:59 GMT
    scheduled
  10. Contract details notice published
    30 Jan 2026, 09:48 GMT
    UK7
Routine re-releases (4)
  • 2025-09: 1 release · 3 Sept 2025

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 92 awards · see the list ↓
Bids received 83 from SMEs
Named bidders 8published on the award notice
Contracts signed 1latest 5 Jan 2026
Awarded toValueDateStatus
ACCORD-UK LTD, Celix Pharma Ltd., Dr Reddy's Laboratories (UK) Ltd, Farmak PharmaceuticalsSME, Glenmark Pharmaceuticals Europe Ltd, Teva UK Ltd +2 moreLot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin1 Feb 2026 – 30 Sept 2027 · up to 30 Sept 2029Extensions: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months£25,881,00025 Nov 2025standstill to 8 Dec 2025Standstill

Contracts

  • Lot 1 - CM/TNS/25/5735 Apremilast, Pazopanib and Dapagliflozin

    Signed
    5 Jan 2026
    Value
    £25,881,000
    Period
    1 Feb 2026 – 30 Sept 2027 · up to 30 Sept 2029 with extensions
    Status
    active
    Extensions
    Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

Bid statistics published by the authority

BidsSMEVCSEValid bid range
8final-stage tenders · 18 at stage one30—

Who bid

Bidders as named on the Procurement Act 2023 award notice. “Won” means the bidder holds an award on this notice.

Contracting authority & participating public bodies

NHS England

Contracting authorityPublic authority - central government GB-PPON: PDPT-3135-BWWY Wellington House, 133-135 Waterloo Rd, London, London, SE1 8UGContact email

Framework contractors & participating bidders

9 commercial parties on the notice
  • ACCORD-UK LTDFramework contractorGB-COH: 00079585 Whiddon Valley, Devon, South West, EX32 8NSContact email
  • AMAROX LIMITEDFramework contractorGB-COH: 10997632 Congress House 14 Lyon Road, Harrow, London, HA1 2ENContact email
  • CELIX PHARMA LTDFramework contractorGB-COH: 12474195 12 Constance Street, London, London, E16 2DQContact email
  • DR REDDY'S LABORATORIES (UK) LIMITEDFramework contractorGB-COH: 01729064 410 Cambridge Science Park Milton Road, Cambridge, East of England, CB4 0PEContact email
  • Farmak Pharmaceuticals UK LtdFramework contractorGB-COH: 15398948 47 Queen Street, Hull, Yorkshire & Humber, HU1 1UUContact email
  • GLENMARK PHARMACEUTICALS EUROPE LIMITEDFramework contractorGB-COH: 05040260 2-B Laxmi House, Harrow, London, HA3 0BUContact email
  • TEVA UK LIMITEDFramework contractorGB-COH: 00302461 Ridings Point, Castleford, Yorkshire & Humber, WF10 5HXContact email
  • THORNTON & ROSS LIMITEDFramework contractorGB-COH: 00185947 Linthwaite Labs Manchester Road, Huddersfield, Yorkshire & Humber, HD7 5QHContact email
  • ZENTIVA PHARMA UK LIMITEDFramework contractorGB-COH: 02158996 12 New Fetter Lane, London, London, EC4A 1JPContact email

Official documents & specifications (17)

Official links; attachments are not copied

Tender pack and attachments

Show 5 more documents

Notices published for this procedure